JP2001501458A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501458A5
JP2001501458A5 JP1998510126A JP51012698A JP2001501458A5 JP 2001501458 A5 JP2001501458 A5 JP 2001501458A5 JP 1998510126 A JP1998510126 A JP 1998510126A JP 51012698 A JP51012698 A JP 51012698A JP 2001501458 A5 JP2001501458 A5 JP 2001501458A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998510126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001501458A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/015270 external-priority patent/WO1998006864A2/en
Publication of JP2001501458A publication Critical patent/JP2001501458A/ja
Publication of JP2001501458A5 publication Critical patent/JP2001501458A5/ja
Withdrawn legal-status Critical Current

Links

JP10510126A 1996-08-15 1997-08-14 ヒートショックタンパク質プロモーターと局部加熱との組合せを利用した遺伝子発現の場所的及び時期的制御 Withdrawn JP2001501458A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2421396P 1996-08-15 1996-08-15
US60/024,213 1996-08-15
PCT/US1997/015270 WO1998006864A2 (en) 1996-08-15 1997-08-14 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008203353A Division JP2008291043A (ja) 1996-08-15 2008-08-06 ヒートショックタンパク質プロモーターと局部加熱との組合せを利用した遺伝子発現の場所的及び時期的制御

Publications (2)

Publication Number Publication Date
JP2001501458A JP2001501458A (ja) 2001-02-06
JP2001501458A5 true JP2001501458A5 (enExample) 2005-04-07

Family

ID=21819426

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10510126A Withdrawn JP2001501458A (ja) 1996-08-15 1997-08-14 ヒートショックタンパク質プロモーターと局部加熱との組合せを利用した遺伝子発現の場所的及び時期的制御
JP2008203353A Ceased JP2008291043A (ja) 1996-08-15 2008-08-06 ヒートショックタンパク質プロモーターと局部加熱との組合せを利用した遺伝子発現の場所的及び時期的制御

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008203353A Ceased JP2008291043A (ja) 1996-08-15 2008-08-06 ヒートショックタンパク質プロモーターと局部加熱との組合せを利用した遺伝子発現の場所的及び時期的制御

Country Status (8)

Country Link
US (2) US7186698B2 (enExample)
EP (1) EP0922110B1 (enExample)
JP (2) JP2001501458A (enExample)
AT (1) ATE392481T1 (enExample)
AU (1) AU732872C (enExample)
CA (1) CA2263706A1 (enExample)
DE (1) DE69738640T2 (enExample)
WO (1) WO1998006864A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342596B1 (en) 1998-05-05 2002-01-29 Hsf Pharmaceuticals S.A. Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
RU2226108C2 (ru) * 1998-08-18 2004-03-27 Рисерч Дивелопмент Фаундейшн Способы усиления и ограничения экспрессии генов
US6900049B2 (en) 1998-09-10 2005-05-31 Cell Genesys, Inc. Adenovirus vectors containing cell status-specific response elements and methods of use thereof
US6684097B1 (en) 1999-04-22 2004-01-27 University Of Miami Intraoperative monitoring of temperature-induced tissue changes with a high-resolution digital x-ray system during thermotherapy
US7115391B1 (en) 1999-10-01 2006-10-03 Genovo, Inc. Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
JP2003511037A (ja) * 1999-10-01 2003-03-25 ジェノボ， インコーポレイテッド ＡＡＶｒｅｐ／ｃａｐ遺伝子を含むアデノウイルスを使用する組換えＡＡＶの産生
US6953659B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
CA2349506C (en) 2001-06-14 2009-12-08 Duke University A method for selective expression of therapeutic genes by hyperthermia
JP4426288B2 (ja) 2001-07-10 2010-03-03 ソノジーン，リミテッド ライアビリティー カンパニー 肝臓へのｄｎａのトランスフェクションの増強
CA2369985A1 (en) * 2002-01-18 2003-07-18 Duke University Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
CN1809641A (zh) * 2003-06-19 2006-07-26 彼得·布罗姆利 蛋白质生产系统
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
AT500838B1 (de) * 2004-04-20 2007-11-15 Veterinaermedizinische Uni Wie Multiple hse
CA2606858A1 (en) * 2005-05-03 2006-11-09 Veterinarmedizinische Universitat Wien Permeable capsules
EP1920057A4 (en) 2005-08-03 2009-03-18 Grains Res & Dev Corp POLYSACCHARIDE synthases
US7774057B2 (en) * 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
US7871406B2 (en) * 2006-08-04 2011-01-18 INTIO, Inc. Methods for planning and performing thermal ablation
ATE499970T1 (de) * 2006-08-22 2011-03-15 Koninkl Philips Electronics Nv Vorrichtung zum erhalten von informationen über einen säugetierkörper
WO2009125332A1 (en) * 2008-04-07 2009-10-15 Peter Bromley New and safe procedure for immunization against infectious diseases agents
EP2370583B1 (en) 2008-11-28 2020-07-15 Empresa Brasileira de Pesquisa Agropecuária - EMBRAPA Use of at(n) insertions in promoter elements for controlling the expression levels of coding sequences in plants
US20110127254A1 (en) * 2009-11-30 2011-06-02 Cypress Technology Llc Electric Heating Systems and Associated Methods
WO2013162722A1 (en) * 2012-04-27 2013-10-31 Medtronic Ardian Luxembourg Sarl Methods and devices for localized disease treatment by ablation
US9101745B2 (en) 2013-03-14 2015-08-11 Sonogene Llc Sonochemical induction of ABCA1 expression and compositions therefor
EP3094347A4 (en) * 2014-01-17 2018-04-04 Wake Forest University Health Sciences Methods for enhancing the delivery of active agents
US11504427B2 (en) * 2016-11-22 2022-11-22 The Regents Of The University Of California Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy
US11318330B2 (en) * 2018-09-26 2022-05-03 General Electric Company Neuromodulation techniques
WO2020172515A1 (en) * 2019-02-22 2020-08-27 The Trustees Of Columbia University In The City Of New York Preparing tissues for delivery of therapeutic and diagnostic agents and delivering the agents
WO2021050658A1 (en) * 2019-09-10 2021-03-18 The Regents Of The University Of California Ultrasound-based thermogenetics for immunotherapy
US11176717B2 (en) * 2019-09-26 2021-11-16 Siemens Healthcare Gmbh Guiding protocol development for magnetic resonance thermometry
WO2021150300A1 (en) 2020-01-22 2021-07-29 Massachusetts Institute Of Technology Inducible tissue constructs and uses thereof
US12359208B2 (en) 2020-04-15 2025-07-15 California Institute Of Technology Thermal control of T-cell immunotherapy through molecular and physical actuation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172882B1 (da) 1983-02-07 1999-09-06 Rothwell Property Ltd DNA indeholdende udtrykkelseskontrolregion fra et eukaryot varmechokproteingen, vektor og eukaryot celle indeholdende DNA'e
AU604214B2 (en) 1985-07-31 1990-12-13 Battelle Memorial Institute An improved heat-shock control method and system for the production of competent eukaryotic gene products
JPS63502637A (ja) * 1986-02-06 1988-10-06 ザ、ゼネラル、ホスピタル、コ−ポレ−ション 誘導性熱ショック及び増幅系
WO1987005935A1 (en) * 1986-04-04 1987-10-08 Battelle Memorial Institute At Columbus, Ohio Gene Methods and compositions for expression of competent eukaryotic gene products
ATE67787T1 (de) * 1986-10-15 1991-10-15 Battelle Memorial Institute Verfahren zur herstellung von proteinen mittels induzierbarer expressionssysteme in in-vivovermehrten, genetisch modifizierten eukaryotischen wirtszellen.
US5591632A (en) * 1987-03-02 1997-01-07 Beth Israel Hospital Recombinant BCG
EP0299127A1 (en) * 1987-07-16 1989-01-18 IntraCel Corporation A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein
ZA892518B (en) 1988-04-08 1989-12-27 Intracel Corp Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
WO1990001543A1 (fr) * 1988-07-29 1990-02-22 Intracel Corporation Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
CA2357538A1 (en) * 1989-03-21 1990-10-04 Wisconsin Alumni Research Foundation Expression of exogenous polynucleotide sequences in a vertebrate
US5521084A (en) 1992-11-10 1996-05-28 Biostar, Inc. Bovine heat shock promoter and uses thereof
WO1995000178A1 (en) * 1993-06-25 1995-01-05 Board Of Regents, The University Of Texas System Pore-forming and superantigen encoding toxin cassettes for gene therapy
US5979454A (en) * 1995-05-15 1999-11-09 The Regents Of The University Of California Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
US5490840A (en) * 1994-09-26 1996-02-13 General Electric Company Targeted thermal release of drug-polymer conjugates

Similar Documents

Publication Publication Date Title
JP2001502189A5 (enExample)
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501324A5 (enExample)
JP2000503235A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2001503266A5 (enExample)
JP2001501458A5 (enExample)
JP2000501744A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)
JP2000512701A5 (enExample)
JP2000502479A5 (enExample)
JP2000502497A5 (enExample)